REYON Pharmaceutical Co., Ltd. (KRX:102460)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,330
-20 (-0.18%)
At close: Aug 8, 2025, 3:30 PM KST
-0.18%
Market Cap205.42B
Revenue (ttm)148.04B
Net Income (ttm)4.04B
Shares Out18.34M
EPS (ttm)220.05
PE Ratio50.90
Forward PEn/a
Dividend150.00 (1.34%)
Ex-Dividend Daten/a
Volume12,000
Average Volume17,936
Open11,260
Previous Close11,350
Day's Range11,260 - 11,460
52-Week Range9,830 - 18,650
Beta0.74
RSI38.33
Earnings DateAug 14, 2025

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ... [Read more]

Sector Healthcare
Founded 1955
Employees 448
Stock Exchange Korea Stock Exchange
Ticker Symbol 102460
Full Company Profile

Financial Performance

In 2024, REYON Pharmaceutical's revenue was 148.30 billion, a decrease of -1.83% compared to the previous year's 151.07 billion. Earnings were 4.15 billion, an increase of 15.85%.

Financial Statements

News

There is no news available yet.